Atea Pharmaceuticals Inc.
AVIR
|
|
| |
|
| Trading Volume | 10,154 |
|
|
4.56 - 2.80 |
| Market Cap Full | $ 315.4M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 4.5% | 32.5% | -30.4% | -19.5% |
| Q2 | - | -15.7% | 11.6% | -1.4% |
| Q3 | - | -1.3% | -19.8% | -19.9% |
| Q4 | - | -2.3% | 1.7% | -15.5% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.5 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 36.4 | 3.6 | -6.3 | -7.9 | -1.3 | -8.2 | 13.5 | -1.3 | - | - | - | -1.8 |
| 2023 | |||||||||||
| -3.7 | -23.5 | -5.4 | -2.4 | 22 | -6.3 | -8.3 | -2 | -10.7 | 8.3 | -8 | 2 |
| 2022 | |||||||||||
| -20.1 | -11.2 | 13.6 | -15.7 | 30.7 | -10.5 | 13.8 | -7.7 | -23.7 | 5.5 | -21.8 | 2.6 |
| 2021 | |||||||||||
| 78.4 | 8.5 | -25.5 | -58.1 | -17.3 | 5.2 | 16.6 | 18.7 | 18 | -66.8 | -30 | 9.7 |
| 2020 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | 11.9 | 20.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.4 | -0.5 | 0.3 | 0 |
| Q2 | -0.3 | -0.4 | 0 | 0 |
| Q3 | -0.4 | -0.1 | -0.3 | 0 |
| Q4 | 0 | -0.4 | 1.4 | 0 |
| A | -1.17 | -1.4 | 1.4 | -0.5 |